Find support for patients taking IMBRUVICA® for CLL or SLL, including support groups, CLL patient stories, and more. See full Prescribing & Safety Info.
candidate genes in a set of 169 additional CLL patients, we used a combination of PCR amplification and Illumina sequencing in pooled samples, resulting in efficient identification of germline and somatic mutations (Supplementary Information). Sequencing data were aligned to the human reference genome ...
Even with the availability of targeted drugs, allogeneic hematopoietic cell transplantation (allo-HCT) is the only therapy with curative potential for patients with CLL. Cure can be assessed by comparing long-term survival of patients to the matched general population. Using data from 2589 patients ...
LC advocates for increased access to appropriate and adequate medical information for patients, and that this information be contextualized to the patient's needs.Information needs of patients with lymphoma compared by regions.Areas of informational needsEU(%)NA(%)P-valueOR*,**(95% CI)Diagnosis ...
Watch Real Stories From Real Patients Loading...Loading... Important Safety Information About CALQUENCE® (acalabrutinib)Before taking CALQUENCE, tell your healthcare provider about all of your medical conditions, including if you: have had recent surgery or plan to have surgery. Your healthcare...
传统的CLL/SLL一线治疗为化疗、免疫疗法以及靶向CD20的单克隆抗体(mAb)的各种组合治疗策略,而Bruton酪氨酸激酶抑制剂(BTKi)和其他新型靶向疗法(Bcl-2抑制剂和PI3K抑制剂)的出现,极大地改变了CLL/SLL的治疗格局。 第一代BTKi可通过“不可逆结合”抑制BCR信号通路中下游激酶的磷酸化,阻断B细胞激活,从而阻止B淋巴瘤...
a For Press/Media Registration, please see thePress and Media pageon the website for more information. ◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。 ※相关服务※ ...
COPIKTRA (duvelisib) is an oral treatment for chronic lymphocytic leukemia or small lymphocytic leukemia (CLL or SLL). See Full Prescribing Information including BOXED WARNING. Copiktra is indicated for the treatment of adult patients with relapsed or re
Jennifer Woyach, MD, discusses the frontline options for the treatment of patients with chronic lymphocytic leukemia.
CALQUENCE is also indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). IMPORTANT SAFETY INFORMATION ABOUT CALQUENCE® (acalabrutinib) tablets Serious and Opportunistic Infections Fatal and serious infections, including opportunistic infec...